Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarik Khan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annual Review of Pharmacology and Toxicology|January 6, 2022
Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery TechnologiesSusanne Page, Tarik Khan, Peter Kühl, et al.
Mabs|May 16, 2023
High concentration formulation developability approaches and considerationsJonathan Zarzar, Tarik Khan, Maniraj Bhagawati, et al.
International Journal of Molecular Sciences|December 21, 2017
Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) PhenomenonWilmar Correa, Klaus Brandenburg, Ulrich Zähringer, et al.
World Neurosurgery|July 12, 2019
Footprint of Reports From Low- and Low- to Middle-Income Countries in the Neurosurgical Data: A Study From 2015 to 2017Franco Servadei, Maria Pia Tropeano, Riccardo Spaggiari, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annual Review of Pharmacology and Toxicology|January 6, 2022
Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery TechnologiesSusanne Page, Tarik Khan, Peter Kühl, et al.
Mabs|May 16, 2023
High concentration formulation developability approaches and considerationsJonathan Zarzar, Tarik Khan, Maniraj Bhagawati, et al.
International Journal of Molecular Sciences|December 21, 2017
Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) PhenomenonWilmar Correa, Klaus Brandenburg, Ulrich Zähringer, et al.
World Neurosurgery|July 12, 2019
Footprint of Reports From Low- and Low- to Middle-Income Countries in the Neurosurgical Data: A Study From 2015 to 2017Franco Servadei, Maria Pia Tropeano, Riccardo Spaggiari, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
Pageof 1